RxDoctor Payments Data

Alan Ikeda

Pediatric Hematology-Oncology · Las Vegas, NVNPI 1154594885

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,100 of the $1,403 with a category attached, or 78.4%. Amgen accounts for 79.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $1,114 and has fallen 92.9% since, to $79 in 2025.

$1,403in general payments, 2019–2025

Across 9 payments — averaging $155.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Adaptive Biotechnologies Corporation$146
  • USWM, LLC$75
  • Novartis$57
  • Merck$11
$496,670in research payments, 2019–2025

Across 148 payments — averaging $3355.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$275K
  • Amgen$80K
  • Boehringer Ingelheim$36K
  • Merck$27K
  • Dova Pharmaceuticals$17K
  • Sobi, Inc$17K
  • plus $45K from 11 others

What the payments were for

  • Consulting fees$1,10078%
  • Food & beverage$29221%
  • Education$111%

General payments by program year

20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)2$1,114
Adaptive Biotechnologies Corporation1$146
USWM, LLC3$75
Novartis2$57
Merck1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric hematology-oncology providers in Nevadato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$3,274

Paid to pharmacies, not to this prescriber.

Other pediatric hematology-oncology in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →